Study Stopped
Study was stopped due to COVID-19 pandemic.
Impact of Hyponatremia on Muscle Strength, Gait and Cognitive Function
1 other identifier
observational
8
1 country
1
Brief Summary
In this study patients with hyponatremia, defined as a serum sodium \< 126 mmol/L on admission to the hospital will be tested for muscular power by use of a hand grip dynamometer, for cognitive function by use of the Montreal-Cognitive-Assessment and gait stability by use of the Tinetti test. The tests will be performed on admission as well es after correction of hyponatremia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2019
CompletedFirst Posted
Study publicly available on registry
July 16, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedJune 25, 2020
June 1, 2020
6 months
July 10, 2019
June 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Muscle strength
A.) Change in muscle strength in kilogram before and after correction of hyponatremia.
Correction of hyponatremia (up to 1 week).
Mobility assessment
B.) Change in results for the Tinetti performance-oriented mobility assessment (POMA) to evaluate static and dynamic balance abilities during and after correction of hyponatremia.
Correction of hyponatremia (up to 1 week).
Cognitive Function
C.) Change in results for the Montreal Cognitive Assessment (MOCA) test to assess mild cognitive impairment before and after correction of hyponatremia.
Correction of hyponatremia (up to 1 week).
Eligibility Criteria
We will include all consecutive patients \>/= 18 years with a serum sodium level \< 126 mmol/L on admission to the Hospital who give consent.
You may qualify if:
- age 18 years or above
- serum sodium ≤ 125 mmol/L
- informed consent.
You may not qualify if:
- age \< 18 years
- not give or are not able to give informed consent
- K+\<3.5 mmol/l
- K+\>5.0 mmol/l)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Buergerspital Solothurn
Solothurn, Canton of Solothurn, 4500, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gregor Lindner, M.D.
Dept. of Internal and Emergency Medicine, Buergerspital Solothurn, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director Dept. of Internal and Emergency Medicine
Study Record Dates
First Submitted
July 10, 2019
First Posted
July 16, 2019
Study Start
October 1, 2019
Primary Completion
March 31, 2020
Study Completion
March 31, 2020
Last Updated
June 25, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share